Management of vascular lesions using advanced laser technology

Abstract - 142 PDF - 41
Christofer Tzermias, Areti Eleftheriadi, Ioulia Gkiouzepaki


One of the most widely used cutaneous applications of Light Amplification by Stimulated Emission of Radiation (laser) concerns the treatment of vascular lesions. During the past two decades, very significant advances in the application of laser technology in dermatology have occurred, with selective photothermolysis being the most important. This review focuses on the application of modern laser devices (Pulsed Dye Laser, or PDL; potassium titanyl phosphate laser, or KTP; diode laser; and neodymium-doped yttrium-aluminium-garnet laser, or Nd:YAG), as well as the combination of laser and photodynamic therapy (PDT) for the treatment of vascular lesions. In particular, both congenital (haemangiomas and port-wine stains) and acquired vascular lesions (facial and leg telangiectasias, rosacea, Poikiloderma of Civatte, spider angioma, pyogenic granuloma, and venous lakes) are discussed. The review of many recent research studies demonstrates that modern applications of lasers in dermatology constitute the finest method for the treatment of vascular lesions, combining the advantages of invasive therapy with the security offered by non-invasive therapy, while in certain cases they are the single and only choice for the treatment of these lesions.


Vascular lesions; laser; PDL; Nd:YAG; PDT

Full Text:



Anderson RR, Parish JA. Selective photothermolysis: Precise microsurgery by selective absorption of pulsed radiation. Science 1983; 220(4596): 524–527. doi: 10.1126/science.6836297.

Adamič M, Troilius A, Adatto M, Drosner M, Dahmane R. Vascular lasers and IPLS: Guidelines for care from the European Society for laser Dermatology (ESLD). J Cosmet Laser Ther 2007; 9(2): 113–124. doi: 10.1080/14764170701280693.

Bruscino N, Bonan P, Cannarozzo G, Moretti S, Lotti T, et al. Laser use in infantile hemangiomas, when and how. Dermatol Ther 2012; 25(4): 314–321. doi: 10.1111/j.1529-8019.2012.01466.x.

Laser treatment for skin problems. Drug Ther Bull 2004; 42: 73–76. doi: 10.1136/dtb.2004.421073.

Scheibner A, Wheeland RG. Use of the argon-pumped tunable dye laser for port-wine stains in children. J Dermatol Surg Oncol 1991; 17(9): 735–739. doi: 10.1111/j.1524-4725.1991.tb03428.x.

Richter GT and Friedman AB. Hemangiomas and vascular malformations: Current theory and management. Int J Pediatr 2012; 2012: 645678. doi: 10.1155/2012/645678.

Léauté-Labrèze C, Prey S, Ezzedine K. Infantile haeman-gioma: Part 1. Pathophysiology, epidemiology, clinical features, life cycle and associated structural abnormalities. J Eur Acad Dermatol Venereol 2011; 25(11): 1245–1253. doi: 10.1111/j.1468-3083.2011.04102.x.

Stier MF, Glick SA, Hirsch RJ. Laser treatment of pediatric vascular lesions: Port wine stains and hemangiomas. J Am Acad Dermatol 2008; 58(2): 261–285. doi: 10.1016/j.jaad.2007.10.492.

Alster TS, Tanzi EL. Combined 595-nm and 1,064-nm laser irradiation of recalcitrant and hypertrophic portwine stains in children and adults. Dermatol Surg 2009; 35(6): 914–919. doi: 10.1111/j.1524-4725.2009.01155.x.

Cordisco MR. An update on lasers in children. Curr Opin Pediatr 2009; 21(4): 499–504. doi: 10.1097/MOP.0b 013e32832e084f.

Astner S, Anderson RR. Treating vascular lesions. Dermatol Ther 2005; 18(6): 267–281. doi: 10.1111/j.15 29-8019.2005.05025.x.

Railan D, Parlette EC, Uebelhoer NS, Rohrer TE. Laser treatment of vascular lesions. Clin Dermatol 2006; 24(1): 8–15. doi: 10.1016/j.clindermatol.2005.10.026.

Mariwalla K, Dover JS. The use of lasers in the pediatric population. Skin Therapy Lett 2005; 10(8): 7–9.

Landthaler M, Hohenleutner U. Laser therapy of vascular lesions. Photodermatol Photoimmunol Photomed 2006; 22(6): 324–332. doi: 10.1111/j.1600-0781.2006.00254.x.

Galeckas KJ. Update on lasers and light devices for the treatment of vascular lesions. Semin Cutan Med Surg 2008; 27(4): 276–284. doi: 10.1016/j.sder.2008.08.002.

Apfelberg DB, Maser MR, Lash H, Rivers J. The argon laser for cutaneous lesions. JAMA 1981; 245(20): 2073–2075. doi: 10.1001/jama.1981.03310450057027.

França K, Chacon A, Ledon J, Savas J, Izakovic J, et al. Lasers for cutaneous congenital vascular lesions: A com-prehensive overview and update. Lasers Med Sci 2013; 28(4): 1197–1204. doi: 10.1007/s10103-012-1220-2.

Ulrich H, Bäumler W, Hohenleutner U, Landthaler M. Neodymium-YAG laser for hemangiomas and vascular malformations—Long term results. J Dtsch Dermatol Ges 2005; 3(6): 436–440. doi: 10.1111/j.1610-0387.20 05.05723.x.

Angiero F, Benedicenti S, Benedicenti A, Arcieri K, Bernè E. Head and neck hemangiomas in pediatric patients treated with endolesional 980-nm diode laser. Photomed Laser Surg 2009; 27(4): 553–559. doi: 10.1089/pho.2008.2362.

Chinnadurai S, Sathe NA, Surawicz T. Laser treatment of infantile hemangioma: A systematic review. Lasers Surg Med 2016; 48(3): 221–233. doi: 10.1002/lsm.22455.

Rizzo C, Brightman L, Chapas AM, Hale EK, Canta-tore-Francis JL, et al. Outcomes of childhood hemangio-mas treated with the pulsed dye laser with dynamic cooling: A retrospective chart analysis. Dermatol Surg 2009; 35(12): 1947–1954. doi: 10.1111/j.15 24-4725.2009.01356.x.

Woo SH, Ahn HH, Kim SN, Kye YC. Treatment of vas-cular skin lesions with the variable pulse 595 nm pulsed dye laser. Dermatol Surg 2006; 32(1): 41–48. doi: 10.1097/00042728-200601000-00007.

Kono T, Sakurai H, Groff WF, Chan HH, Takeuchi M, et al. Comparison study of a traditional pulsed dye laser versus a long-pulsed dye laser in the treatment of early childhood hemangiomas. Lasers Surg Med 2006; 38(2): 112–115. doi: 10.1002/lsm.20257.

Kessels JP, Hamers ET, Ostertag JU. Superficial hemangioma: Pulsed dye laser versus wait-and-see. Dermatol Surg 2013; 39(3 Pt 1): 414–421. doi: 10.1111/dsu.12081.

Zhong S, Tao Y, Zhou J, Liu Y, Yao L, et al. Infantile hemangioma: Clinical characteristics and efficacy of treatment with the long-pulsed 1,064-nm neodymi-um-doped yttrium aluminum garnet laser in 794 Chinese patients. Pediatr Dermatol 2015; 32(4): 495–500. doi: 10.1111/pde.12593.

Kaune KM, Lauerer P, Kietz S, Eich C, Thoms KM, et al. Combination therapy of infantile hemangiomas with pulsed dye laser and Nd:YAG laser is effective and safe. J Deutsch Dermatol Ges 2014; 12(6): 473–478. doi: 10.1111/ddg.12354.

Cerrati EW, March TMO, Chung H, Waner M. Diode laser for the treatment of telangiectasias following hemangioma involution. Otolaryngol Head Neck Surg 2015; 152(2): 239–243. doi: 10.1177/0194599814559192.

Reddy KK, Blei F, Brauer JA, Waner M, Anolik R, et al. Retrospective study of the treatment of infantile heman-giomas using a combination of propranolol and pulsed dye laser. Dermatol Surg 2013; 39(6): 923–933. doi: 10.1111/dsu.12158.

Willenberg T, Baumgartner I. Vascular birthmarks. VASA 2013; 37(1): 5–17. doi: 10.1024/0301-1526.37.1.5.

Mulliken JB, Glowacki J. Hemangiomas and vascular malformations in infants and children: A classification based on endothelial characteristics. Plast Reconstr Surg 1982; 69(3): 412–422. doi: 10.1097/00 006534-198203000-00002.

Gao Κ, Huang Ζ, Yuan ΚΗ, Zhang Β, Hu ΖQ. Side-by-side comparison of photodynamic therapy and pulsed-dye laser treatment of port-wine stain birthmarks. Br J Dermatol 2013; 168(5): 1040–1046. doi: 10.1111/bjd.12130.

Geronemus RG. Argon laser for the treatment of cutaneous lesions. Clin Dermatol 1995; 13(1): 55–58. doi: 10.1016/0738-081X(94)00027-Y.

Liu H, Dang Y, Chai X, Wang Z, Ma L, et al. Treatment of port-wine stains with the 595-nm pulsed dye laser: A pilot study in Chinese patients. Clin Exp Dermatol 2007; 32(6): 646–649. doi: 10.1111/j.1365-2230.2007.02517.x.

Faurschou A, Togsverd-Bo K, Zachariae C, Hædersdal M. Pulsed dye laser vs. intense pulsed light for port-wine stains: A randomized side-by-side trial with blinded re-sponse evaluation. Br J Dermatol 2009; 160(2): 359–364. doi: 10.1111/j.1365-2133.2008.08993.x.

Kono T, Groff WF, Sakurai H. Treatment of port wine stains with the pulse dye laser. Ann Plast Surg 2006; 56(4): 460–463. doi: 10.1097/ 00201554.44010.44.

Yuan KH, Li Q, Yu WL, Huang Z. Photodynamic therapy in treatment of port wine stain birthmarks—Recent pro-gress. Photodiagnosis Photodyn Ther 2009; 6(3–4): 189–194. doi: 10.1016/j.pdpdt.2009.08.001.

Chapas AM, Eickhorst K, Geronemus R. Efficacy of early treatment of facial port wine stains in newborns: A review of 49 cases. Lasers Surg Med 2007; (39)7: 563–568. doi: 10.1002/lsm.20529.

Kelly KM, Choi B, McFarlane S, Motosue A, Jung B, et al. Description and analysis of treatments for port-wine stain birthmarks. Arch Facial Plast Surg 2005; 7(5): 287–294. doi: 10.1001/archfaci.7.5.287.

Li L, Kono T, Groff WF, Chan HH, Kitazawa Y, et al. Comparison study of a long-pulse pulsed dye laser and a long-pulse pulsed alexandrite laser in the treatment of port-wine stains. J Cosmet Laser Ther 2008; 10(1): 12–15. doi: 10.1080/14764170701817023.

Izikson L, Nelson JS, Anderson RR. Treatment of hyper-trophic and resistant port wine stains with a 755 nm laser: A case series of 20 patients. Lasers Surg Med 2009; 41(6): 427–432. doi: 10.1002/lsm.20793.

Yang MU, Yaroslavsky AN, Farinelli WA, Flotte TJ, Rius-Diaz F, et al. Long-pulsed neodymium:yttrium- aluminum-garnet laser treatment for port-wine stains. J Am Acad Dermatol 2005; 52(3): 480–490. doi: 10.1016/j.jaad.2004.10.876.

Jasim ZF, Handley JM. Treatment of pulsed dye la-ser-resistant port-wine stain birthmarks. J Am Acad Der-matol 2007; 57(4): 677–682. doi: 10.1016/j.ja ad.2007.01.019.

Xing L, Li D, Chen B, Dai Y, Wu W, et al. Enhancement of light absorption by blood to Nd:YAG laser using PEG-modified gold nanorods. Lasers Surg Med 2016; 48(8): 790–803. doi: 10.1002/lsm.22557.

Wenxin Yu, Ma G, Qiu Y, Chen H, Jin Y, et al. Why do port-wine stains (PWS) on the lateral face respond better to pulsed dye laser (PDL) than those located on the central face? J Am Acad Dermatol 2016; 74(3): 527–535. doi: 10.1016/j.jaad.2015.08.026.

Adamič M, Pavlović MD, Troilius Rubin A, Pal-metun-Ekbäck M, Boixeda P. Guidelines of care for vas-cular lasers and intense pulse light sources from the European Society for Laser Dermatology. J Eur Acad Dermatol Venereol 2015; 29(9): 1661–1678. doi: 10.1111/jdv.13177.

Liu S, Yang C, Yang S, Wang Z, Luo D, et al. Topical application of 5-aminolevulinic acid followed by 595-nm pulsed dye laser irradiation for the treatment of recalcitrant port-wine stains: A primary study. J Cosmet Laser Ther 2012; 87(6): 189–192. doi: 10.3109/14764 172.2012.699677.

Sivarajan V, Maclaren WM, Mackay IR. The effect of varying pulse duration, wavelength, spot size, and fluence on the response of previously treated capillary vascular malformations to pulsed-dye laser treatment. Ann Plast Surg 2006; 57(1): 25–32. doi: 10.1097/ 00208942.15897.15.

Zelickson BD. Mechanism of action of topical ami-nolevulinic acid. 2nd ed. In: Goldman MP (editor). Pho-todynamic therapy. Philadelphia, PA: Saunders Elsevier; 2008. p. 1–9.

Babilas P, Landthaler M, Szeimies RM. Photodynamic therapy in dermatology. Eur J Dermatol 2006; 16(4): 340–348.

Qin ZP, Li KL, Li R, Liu XJ. Photodynamic therapy of port wine stains—A report of 238 cases. Photodiagnosis Photodyn Ther 2007; 4(1): 53–59. doi: 10.10 16/j.pdpdt.2007.01.001.

Qiu H, Gu Y, Wang Y, Huang N. Twenty years of clinical experience with a new modality of vascular-targeted photodynamic therapy for port wine stains. Dermatol Surg 2011; 37(11): 1603–1610. doi: 10.1111/j.1524-47 25.2011.02129.x.

Tournas JA, Lai J, Truitt A, Huang YC, Osann KE, et al. Combined benzoporphyrin derivative monoacid ring photodynamic therapy and pulsed dye laser for port wine stain birthmarks. Photodiagnosis Photodyn Ther 2009; 6(34): 195–199. doi: 10.1016/j.pdpdt.2009.10.002.

Alam M, Dover JS, Arndt KA. Treatment of facial telan-giectasia with variable-pulse high-fluence pulsed-dye laser: Comparison of efficacy with fluences immediately above and below the purpura threshold. Dermatol Surg 2003; 29(7): 681–684. doi: 10.1097/00042728-20 0307000-00001.

Nymann P, Hedelund L, Hædersdal M. Long-pulsed dye laser vs. intense pulsed light for the treatment of facial telangiectasias: A randomized controlled trial. J Eur Acad Dermatol Venereol 2010; 24(2): 143–146. doi: 10.11 11/j.1468-3083.2009.03357.x.

Clark C, Cameron H, Moseley H, Ferguson J, Ibbotson SH. Treatment of superficial cutaneous vascular lesions: Experience with the KTP 532 nm laser. Lasers Med Sci 2004; 19(1): 1–5. doi: 10.1007/s10103-004-0294-x.

Ozyurt K, Colgecen E, Baykan H, Ozturk P, Ozkose M. Treatment of superficial cutaneous vascular lesions: Ex-perience with the long-pulsed 1064 nm Nd:Yag laser. ScientificWorldJournal 2012; 2012: 197139. doi: 10.1100/2012/197139.

Rose AE, Goldberg DJ. Successful treatment of facial telangiectasias using a micropulse 1,064-nm neodymium-doped yttrium aluminum garnet laser. Dermatol Surg 2013; 39(7): 1062–1066. doi: 10.1111/dsu.12185.

Bäumler W, Ulrich H, Hartl A, Landthaler M, Shafirstein G. Optimal parameters for the treatment of leg veins using Nd:Yag lasers at 1064 nm. Br J Dermatol 2006; 155(2): 364–371. doi: 10.1111/j.1365-2133.2006.07 314.x.

Athavale SM, Ries WR, Carniol PJ. Laser treatment of cutaneous vascular tumors and malformations. Facial Plast Surg Clin North Am 2011; 19(2): 303–312. doi: 10.1016/j.fsc.2011.05.009.

Srinivas CR, Kumaresan M. Lasers for vascular lesions: Standard guidelines of care. Indian J Dermatol Venereol Leprol 2011; 77(3): 349–368. doi: 10.4103/0378-63 23.79728.

Bevin AA, Parlette EC, Yacov D, Ross EV. Variable pulse Nd:YAG laser in the treatment of facial telangiectasias. Dermatol Surg 2006; 32(1): 7–12. doi: 10.10 97/00042728-200601000-00002.

Meesters AA, Pitassi LHU, Campos V, Wolkerstorfer A, Dierickx CC. Transcutaneous laser treatment of leg veins. Lasers Med Sci 2014; 29(2): 481–492. doi: 10.1007/s10103-013-1483-2.

Bernstein EF, Kligman A. Rosacea treatment using the new-generation, high-energy, 595 nm, long pulse-duration pulsed-dye laser. Lasers Surg Med 2008; 40(4): 233–239. doi: 10.1002/lsm.20621.

Menezes N, Moreira A, Mota G, Baptista A. Quality of life and rosacea: Pulsed dye laser impact. J Cosmet Laser Ther 2009; 11(3): 139–141. doi: 10.1080/147 64170902741311.

Jasim ZF, Woo WK, Handley JM. Long-pulsed (6-ms) pulsed dye laser treatment of rosacea-associated telangiectasia using subpurpuric clinical threshold. Dermatol Surg 2004; 30(1): 37–40.

Shim TN, Abdullah A. The effect of pulsed dye laser on the dermatology life quality index in erythematotelangiectatic rosacea patients: An assessment. J Clin Aesthet Dermatol 2013; 6(4): 30–32.

Mark KA, Sparacio RM, Voigt A, Marenus K, Sarnoff DS. Objective and quantitative improvement of rosacea-associated erythema after intense pulsed light treatment. Dermatol Surg 2003; 29(6): 600–604.

Hu SW, Chu J, Meehan S, Kamino H, Pomeranz MK. Acquired brachial cutaneous dyschromatosis. Dermatol Online J 2011; 17(10): 16.

Meijs MM, Blok FAA, De Rie MA. Treatment of Poikiloderma of Civatte with the pulsed dye laser: A series of patients with severe depigmentation. J Eur Acad Dermatol Venereol 2006; 20(10): 1248–1251. doi: 10.1111/j.1468-3083.2006.01782.x.

Tierney EP, Hanke CW. Treatment of Poikiloderma of Civatte with ablative fractional laser resurfacing: Pro-spective study and review of the literature. J Drugs Der-matol 2009; 8(6): 527–534

Bencini PL, Tourlaki A, De Giorgi V, Galimberti M. Laser use for cutaneous vascular alterations of cosmetic interest. Dermatol Ther 2012; 25(4): 340–351. doi: 10.1111/j.1529-8019.2012.01463.x.

Sivarajan V, Al Aissami M, Maclaren W, Mackay IR. Recurrence of spider naevi following treatment with 585 nm pulsed dye laser. J Plast Reconstr Aesthet Surg 2007; 60(6): 668–671. doi: 10.1016/j.bjps.2006.10.012.

Neville BW, Damn DD, Allen CM, Bouquot JE. Oral and maxillofacial pathology. 2nd ed. Philadelphia, PA: WB Saunders; 2002. p. 437–495.

Ting PT, Rao J. Vascular lesions. In: Bogdan Allemann I, Goldberg DJ (editors). Basics in dermatological laser applications. Curr Probl Dermatol 2011; 42: 67–80. doi: 10.1159/000328264.

González S, Vibhagool C, Falo Jr LD, Momtaz KT, Grevelink J, et al. Treatment of pyogenic granulomas with the 585 nm pulsed dye laser. J Am Acad Dermatol 1996; 35(3): 428–431. doi: 10.1016/S0190-9622(96)90 610-6.

Bédard MS, Boulanger J. Treatment of lobular capillary hemangioma with the Nd:YAG laser: Retrospective case series of 25 patients. J Cutan Med Surg 2009; 13(3): 181–182. doi: 10.2310/7750.2008.08053.

Lindenmüller IH, Noll P, Mameghani T, Walter C. CO2 laser-assisted treatment of a giant pyogenic granuloma of the gingiva. Int J Dent Hyg 2010; 8(3): 249–252. doi: 10.1111/j.1601-5037.2010.00449.x.

Akamatsu T, Hanai U, Kobayashi M, Miyasaka M. Pyogenic granuloma: A retrospective 10-year analysis of 82 cases. Tokai J Exp Clin Med 2015; 40(3): 110–114.

Bekhor PS. Long-pulsed Nd:YAG laser treatment of venous lakes: Report of a series of 34 cases. Dermatol Surg 2006; 32(9): 1151–1154. doi: 10.1097/00042728-200 609000-00007.

Roncero M, Cañueto J, Blanco S, Unamuno P, Boixeda P. Multiwavelength laser treatment of venous lakes. Dermatol Surg 2009; 35(12): 1942–1946. doi: 10.1111/j.1524-4725.2009.01357.x.

Azevedo LH, Galletta VC, Eduardo CdeP, Migliari DA. Venous lake of the lips treated using photocoagulation with high-intensity diode laser. Photomed Laser Surg 2010; 28(2): 263–265. doi: 10.1089/pho.2009.2564.

Raulin C, Greve B, Hammes S. Cold air in laser therapy: First experiences with a new cooling system. Lasers Surg Med 2000; 27(5): 404–410. doi: 10.1002/1096-9101(200 0)27:5<404::AID-LSM1001>3.0.CO;2-S.


  • There are currently no refbacks.